Systematic Review and Patient-Level Meta-analysis of the Streamliner Multilayer Flow Modulator in the Management of Complex Thoracoabdominal Aortic Pathology
Restricted accessReview articleFirst published online June, 2016
Systematic Review and Patient-Level Meta-analysis of the Streamliner Multilayer Flow Modulator in the Management of Complex Thoracoabdominal Aortic Pathology
To examine the safety and short-term efficacy of the Streamliner Multilayer Flow Modulator (SMFM) in the management of patients with complex thoracoabdominal aortic pathology who are unfit for alternative interventions.
Methods:
Biomedical databases were systematically searched for articles published between 2008 and 2015 on the SMFM. A patient-level meta-analysis was used to evaluate aneurysm-related survival. Secondary outcomes were all-cause survival, stroke, spinal cord ischemia, renal impairment, and branch vessel patency. Other considerations were the impact of compliance with the instructions for use (IFU) on clinical outcome. Mean values and Kaplan-Meier estimates are presented with the 95% confidence interval (CI).
Results:
Fifteen articles (3 multicenter cohort studies, 3 observational cohort studies, and 9 case reports) were included, presenting 171 patients (mean age 68.8±12.3 years; 139 men). The mean aneurysm diameter was 6.7±1.6 cm (95% CI 6.4 to 6.9 cm). Technical success reported in 15 studies was 77.2%. Aneurysm-related survival at 1 year was 78.7% (95% CI 71.7% to 84.4%). One-year all-cause survival was 53.7% (95% CI 46.0% to 61.3%). There were no reported cases of spinal cord ischemia, renal insult, or stroke.
Conclusion:
The SMFM can be safely utilized in some patients with complex thoracoabdominal pathologies provided operators adhere to the IFU. The SMFM is a novel technology with no long-term published data on its sustained effectiveness and a lack of comparative studies. Randomized clinical trials, registries, and continued assessment are essential before this flow-modulating technology can be widely disseminated.
SultanSHynesNKavanaghEPHow does the Multilayer Flow Modulator work? The science behind the technical innovation. J Endovasc Ther. 2014;21:814–821.
2.
LiberatiAAltmanDGTetzlaffJThe PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65–W94.
AngilettaDMaiellaroLMarinazzoDEndovascular management of type Ib endoleak complicating a juxtarenal aortic aneurysm previously treated with a multilayer stent. Ann Vasc Surg. 2014;28:1799.e9–1799.e13.
5.
ChocronSVaislicCKailiDMultilayer stents in the treatment of thoracoabdominal residual type B dissection. Interact Cardiovasc Thorac Surg. 2011;12:1057–1059.
6.
DebingEAerdenDGallalaSStenting complex aorta aneurysms with the Cardiatis multilayer flow modulator: first impressions. Eur J Vasc Endovasc Surg. 2014;47:604–608.
7.
EuringerWSüdkampMRylskiBEndovascular treatment of multiple HIV-related aneurysms using Multilayer stents. Cardiovasc Intervent Radiol. 2012;35:945–949.
8.
FerreroEGibelloLFerriMAortic arch rupture after multiple multilayer stent treatment of a thoracoabdominal aneurysm. J Vasc Surg. 2014;60:1348–1352.
9.
FlisVMatelaJBreznikSTreatment of primary infected juxtarenal aortic aneurysm with the multilayer stent. Vasc Endovascular Surg. 2013;47:561–565.
10.
HenryMBenjellounAHenryIThe multilayer flow modulator stent for the treatment of arterial aneurysms. J Cardiovasc Surg (Torino). 2013;54:763–783.
11.
LazarisAMMaherasANVasdekisSN. A multilayer stent in the aorta may not seal the aneurysm, thereby leading to rupture. J Vasc Surg. 2012;56:829–831.
12.
NatrellaMCastagnolaMNavarrettaFTreatment of juxtarenal aortic aneurysm with the Multilayer stent. J Endovasc Ther. 2012;19:121–124.
13.
PaneBSpinellaGSalcuniMStent-graft and multilayer stent for treatment of type II thoracoabdominal aortic aneurysm in a high-risk patient. J Cardiovasc Surg (Torino). 2013;54:505–509.
14.
PolydorouAHenryMBelenisIEndovascular treatment of aortic aneurysms: the role of the multilayer stent. Hosp Chronicles. 2012;7:157–159.
15.
SultanSHynesN. One-year results of the Multilayer Flow Modulator Stent in the management of thoracoabdominal aortic aneurysms and type B dissections. J Endovasc Ther. 2013;20:366–377.
16.
SultanSHynesNSultanM; MFM Collaborators. When not to implant the Multilayer Flow Modulator: lessons learned from application outside the indications in patients with thoracoabdominal pathologies. J Endovasc Ther. 2014;21:96–112.
17.
TolvaVSBianchiPGCireniLVMultiple multilayer stents for thoracoabdominal aortic aneurysm: a possible new tool for aortic endovascular surgery. Int J Gen Med. 2012;5:629–632.
18.
VaislicSDFabianiJNChocronSOne-year outcomes following repair of thoracoabdominal aneurysms with the Multilayer Flow Modulator: report from the STRATO trial. J Endovasc Ther. 2014;21:85–95.
19.
SlimKNiniEForestierDMethodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73:712–716.
SchepensMAHeijmenRHRanschaertWThoracoabdominal aortic repair: results of conventional open surgery. Eur J Vasc Endovasc Surg. 2009;37:640–645.
24.
PatelVILancasterRTConradMFOpen surgical repair of thoracoabdominal aneurysms-the Massachusetts General Hospital experience. Ann Cardiothorac Surg. 2012;1:320–324.
25.
SafiHJEstreraALAzizzadehAProgress and future challenges in thoracoabdominal aortic aneurysm management. World J Surg. 2008;32:355–360.
26.
CoselliJSBozinovskiJLeMaireSA. Open surgical repair of 2286 thoracoabdominal aortic aneurysms. Ann Thorac Surg. 2007;83:S862–864.
27.
ConradMFCrawfordRSDavisonJKThoracoabdominal aneurysm repair: a 20-year perspective. Ann Thorac Surg. 2007;83:S856–S861.
28.
MoulakakisKGMylonasSNAntonopoulosCNCombined open and endovascular treatment of thoracoabdominal aortic pathologies: a systematic review and meta-analysis. Ann Cardiothorac Surg. 2012;1:267–276.
29.
ArmstrongNBurgersLDeshpandeSThe use of fenestrated and branched endovascular aneurysm repair for juxtarenal and thoracoabdominal aneurysms: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2014;18:1–66.
RauxMPatelVICochennecFA propensity-matched comparison of outcomes for fenestrated endovascular aneurysm repair and open surgical repair of complex abdominal aortic aneurysms. J Vasc Surg. 2014;60:858–863.
32.
FillingerMFMarraSPRaghavanMLPrediction of rupture risk in abdominal aortic aneurysm during observation: wall stress versus diameter. J Vasc Surg. 2003;37:724–732.
33.
ThubrikarMJRobicsekFLabrosseMEffect of thrombus on abdominal aortic aneurysm wall dilation and stress. J Cardiovasc Surg (Torino). 2003;44:67–77.
34.
GreenhalghTRobertGMacfarlaneFStorylines of research in diffusion of innovation: a meta-narrative approach to systematic review. Soc Sci Med. 2005;61:417–430.
35.
El DibRNascimento JuniorPKapoorA. An alternative approach to deal with the absence of clinical trials: a proportional meta-analysis of case series studies. Acta Cir Bras. 2013;28:870–876.
36.
GreenhalghRMBrownLCKwongGPComparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: randomised controlled trial. Lancet. 2004;364:843–848.
37.
United Kingdom EVAR Trial Investigators, GreenhalghRMBrownLCEndovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med. 2010;362:1872–1880.
38.
PibarotPWeissmanNJStewartWJIncidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial Cohort-A analysis. J Am Coll Cardiol. 2014;64:1323-1334.
39.
DouglasPSHahnRTPibarotPHemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. J Am Soc Echocardiogr. 2015;28:210–217.
